Number One Overall Graft Pick? Hamstring vs Bone-Patellar-Tendon-Bone vs Quadriceps Tendon
1 other identifier
interventional
297
1 country
1
Brief Summary
The main purpose of this study is to determine if there is a difference in graft re-injury/failure rates between participants that have had an ACL reconstruction with a STG, BPTB or QT autograft. Additionally, to compare quality of life, patient reported outcomes and functional performance after ACL reconstruction with STG, BPTB and QT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2018
CompletedStudy Start
First participant enrolled
September 11, 2018
CompletedFirst Posted
Study publicly available on registry
September 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedApril 2, 2024
April 1, 2024
6.2 years
September 11, 2018
April 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
graft re-injury (re-rupture, partial tear) or graft failure
) Diagnosis of a complete graft re-rupture requires all of the following criteria to be met: * associated with an acute traumatic event * a definite loss of end point on manual Lachman testing * increased anterior translation \>3 mm * \> or = Grade 2 pivot shift * tear confirmed as complete on MRI or diagnostic arthroscopy * revision ACL reconstruction IS recommended or required 2\) Diagnosis of a partial re-rupture requires all of the following criteria: * suspected meniscal injury or graft tear on history without the clinical characteristics of a complete rupture * tear confirmed as partial by MRI or diagnostic arthroscopy * revision ACL reconstruction is NOT recommended or required 3\) Diagnosis of graft failure will be defined as: * \>/= Gr. 2 pivot shift and/or \>6 mm side-to-side difference on manual Lachman
24 months
Secondary Outcomes (6)
SANE
24 months
Knee laxity
24 months
Concentric maximal strength
24 months
Pain log
3 weeks post operative
ACL-QOL
24 months
- +1 more secondary outcomes
Study Arms (3)
Quads tendon
ACTIVE COMPARATORThe graft tissue will be quadriceps tendon
Hamstring
ACTIVE COMPARATORSemitendinosus and gracilis will be used for graft
BPTB
ACTIVE COMPARATORBone patellar tendon bone graft to be used.
Interventions
Use of 3 different ipsilateral autograft options
Eligibility Criteria
You may qualify if:
- \- confirmed diagnosis of a complete primary unilateral ACL rupture based on all of the following:
- history of a traumatic injury episode
- physical exam findings of increased anterior translation of the tibia on the femur (Lachman test and/or anterior drawer test)
- positive pivot shift test
- patients must be 14 to \</= 50 years (at time of surgery)
- x-rays showing skeletal maturity (i.e. tibial tubercle fused) and no fractures
- MRI prior to surgery (note: if the radiologist's report states an incomplete or partial ACL on MRI but the surgeon diagnoses the patient with a complete unilateral tear based on the clinical criteria above, then the patient will be considered eligible. Final eligibility will be determined intra-operatively.)
You may not qualify if:
- \- ACL rupture on contra-lateral limb
- Partially torn ACL \*final determination made intra-operatively
- Concomitant medial collateral, lateral collateral, or posterior collateral ligament tears requiring surgical repair \*final determination made intra-operatively
- Severe chondromalacia (Grade IV on the ICRS scale) \*final determination made intra-operatively
- ACL reconstruction using allograft tissue
- Confirmed connective tissue disorder
- Unwillingness to be followed for 24 months post-operatively
- History of rheumatoid arthritis
- Pregnancy (at the time of surgery)
- Psychiatric illness that precludes informed consent
- Unable to speak, read or understand the English language
- Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Panam Cliniclead
Study Sites (1)
Pan Am Clinic
Winnipeg, Manitoba, R3M3E4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The clinical assessments will be done by someone blinded to the arm of the study the patient is in.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department head, orthopaedic surgery
Study Record Dates
First Submitted
September 11, 2018
First Posted
September 14, 2018
Study Start
September 11, 2018
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
April 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share